Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments

Basit Öğe Kaydı
dc.authoridZarrabi, Ali/0000-0003-0391-1769
dc.authoridZarepour, Atefeh/0000-0002-0347-5840
dc.authoridSEZEN, Serap/0000-0003-3382-6020
dc.authoridSelamoglu, Zeliha/0000-0001-9056-6435
dc.contributor.authorVarol, Aysegul
dc.contributor.authorSezen, Serap
dc.contributor.authorEvcimen, Dilhan
dc.contributor.authorZarepour, Atefeh
dc.contributor.authorUlus, Gonul
dc.contributor.authorZarrabi, Ali
dc.contributor.authorBadr, Gamal
dc.date.accessioned2024-11-07T13:35:28Z
dc.date.available2024-11-07T13:35:28Z
dc.date.issued2022
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractBee venom therapy is known as a traditional approach to curing many medical conditions such as arthritis, pain and rheumatism. Bee venom also provides promising potential for treating many cancers such as breast, lung, ovary, stomach, kidney, prostate, cervical, colon and esophageal cancers, osteosarcoma, leukemia, melanoma and hepatocellular carcinoma. We therefore focused not only on the molecular activity mechanisms and cellular targets of bee venom and its components, but also on modern solutions as cutting-edge nanotechnological advances to overcome existing bottlenecks, and the latest advances in the anticancer application of bee venom in clinical settings.
dc.identifier.doi10.1080/15569543.2021.2024576
dc.identifier.endpage1395
dc.identifier.issn1556-9543
dc.identifier.issn1556-9551
dc.identifier.issue4
dc.identifier.scopus2-s2.0-85125340070
dc.identifier.scopusqualityQ3
dc.identifier.startpage1382
dc.identifier.urihttps://doi.org/10.1080/15569543.2021.2024576
dc.identifier.urihttps://hdl.handle.net/11480/16524
dc.identifier.volume41
dc.identifier.wosWOS:000756197300001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofToxin Reviews
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241106
dc.subjectApitherapy
dc.subjectanti-inflammatory drugs
dc.subjectbee venom
dc.subjectcancer
dc.subjectmelittin
dc.titleCellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments
dc.typeReview Article

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu